CAV1 and glioblastoma: Fenretinide, a synthetic derivative of retinoic acid, led to the down-regulation of caveolin-1 expression at the protein level in MG-63 and HOS osteosarcoma and A-172,LI,CRS-A2 glioblastoma cells, decreasing tumor aggressiveness and restoring chemosensitivity.